THURSDAY, MAY 25, 2017

Tests of new chikungunya fever vaccine successful

chikungunya virus Read More »

Study identifies potential for pandemic flu viruses

Influenza Read More »

Janssen enters collaboration with ViiV Heathcare to develop single-tablet HIV treatment

Janssen R&D Ireland, Ltd., announced on Thursday that it had entered an agreement with ViiV Healthcare to develop a single-tablet regimen for maintenance treatment of HIV. Read More »

Study eliminates female malaria-carrying mosquitoes

Mosquito Read More »

Mireille Guigaz elected as Bioforce Institute chair

Mireille Guigaz Read More »

Themis Bioscience Chikungunya vaccine candidate shows successful first trial

chikungunya virus Read More »

Researchers discover malaria genetic "barcode"

Malaria Read More »

Copper surfaces could inactivate Middle East Respiratory Syndrome

MERS-CoV Read More »

Alere influenza test receives FDA approval

Alere, Inc., announced on Monday that it received clearance from the U.S. Food and Drug Administration for its Alere i Influenza A & B test. Read More »

Whooping cough reaches epidemic proportions in California

Ron Chapman Read More »

Novartis receives FDA licensing for cell-culture influenza vaccine production in U.S.

Novartis announced on Monday that it received licensing from the U.S. Food and Drug Administration to produce cell-culture influenza vaccines at its manufacturing facility in Holly Springs, N.C. Read More »

U.S. sees record-breaking reports of measles cases

Measles Read More »

WHO Emergency Committee holds sixth meeting on MERS-CoV

The World Health Organization held the sixth meeting of its Emergency Committee concerning Middle East respiratory syndrome coronavirus (MERS-CoV) on Monday by teleconference. Read More »

Oral regimen for Hepatitis C treatment receives MAA validation

hepatitis C Read More »

Novartis submits application to FDA for Bexsero meningitis vaccine

Novartis announced the submission on Tuesday of a Biologic License Application for its Bexsero meningitis B vaccine to the U.S. Food and Drug Administration. Read More »

Selecta Biosciences receives malaria research grant from Bill & Melinda Gates Foundation

Selecta Biosciences received a $1.25 million grant from the Bill & Melinda Gates Foundation on Tuesday to support research on a novel dual action, immune-activating Synthetic Vaccine Particle (SVP) for malaria. Read More »

CDC confirms U.S. MERS-CoV patients did not spread virus to high-risk contacts

MERS-CoV Read More »

Genome of yellow fever-carrying mosquitoes mapped

Aedes Mosquito Read More »

Mississippi investigates possible chikungunya virus case

chikungunya virus Read More »

Walgreens offers measles vaccine in Ohio

As of Wednesday, citizens of Ohio can visit any of the state's 250 Walgreens pharmacy without an appointment to receive the measles, mumps and rubella (MMR) vaccine. Read More »